Insmed Incorporated
Clinical trials sponsored by Insmed Incorporated, explained in plain language.
-
New hope for PAH patients: daily inhaler aims to boost stamina
Disease control Not yet recruitingThis study aims to see if a new once-daily inhaled powder can help adults with pulmonary arterial hypertension (PAH) walk farther and feel better. It will compare the new treatment to a placebo (inactive powder) over 24 weeks in about 344 people who are already on stable PAH medi…
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New inhaled powder aims to help people breathe easier with serious lung condition
Disease control Not yet recruitingThis study is checking the long-term safety of an inhaled powder medicine for people who have both lung scarring and high blood pressure in their lungs. It's for people who have already finished a previous related study. The main goal is to see how well people tolerate the medici…
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC